GMO Salmon Near FDA Approval - Public's Input Not Wanted
The modified fish, called AquAdvantage® by their developer, AquaBounty Technologies, grow to market size very quickly. AquaBounty claims the fish can be ready for sale in 16-18 months instead of the usual 3 years for standard farmed salmon.
What We Know...
AquaBounty implanted two genes into the genetically engineered salmon. One is a growth hormone gene from Chinook salmon of the Pacific Ocean, and the other is a gene from the pout fish that turns the growth hormone gene on. These keep salmon from turning their growth hormones off when it's cold, so they continue to grow.
The FDA's approval process requires submission of seven data sets. The first five have been approved. AquaBounty believes the last two sets are close to approval.
Even more revealing, though, is that the FDA has been discussing whether to require labeling of the GMO salmon—which sounds very much like they've already decided to approve AquaBounty's salmon. As it now stands, the FDA does not require any other GMO food to be labeled, unless it's significantly different from its natural counterpart or contains an allergen that the natural form doesn't. There's a belief that the public is "confused" by being informed.
AquaBounty's CEO, Ronald L. Stotish, tries to create the image that their purpose is to benefit humanity. He has said that the GM fish would help grow food for the world with fewer resources. Of course, it ignores the massive amount of food the fish will need to grow so fast, the land required to provide the feed for the fish, transportation for getting feed to the fish, and the use of land that might grow vegetables or grass to graze animals for far less efficient food production in the fish. With so little basis in reality on this point, it's difficult to believe any of AquaBounty's statements about safety, health, or environmental standards.
...And What We Don't Know
The method used to transfer genes is not being provided to the public. If a virus was used as a vector to transfer the genes, then the potential for inducing cancer in people who eat the salmon exists. The FDA does not seem to believe that we have the right to know what gene-transfer technique is used.
Gut bacteria, present in everyone and necessary for life, are known to exchange genes. A study by the UK's Food Standards Agency has shown that horizontal gene transfer can occur with a single serving of food. Is this possible with AquAdvantage salmon? We don't know, and the FDA asks us to trust them that they'll make the right decision.
Do the transferred genes produce new proteins that could be allergenic in some people? Again, we have only the word of the corporation that hopes to profit from the sale that a deadly allergen isn't created by their product.
The nutritional quality and taste of the GM salmon is supposedly indistinguishable from natural Atlantic salmon. That's what AquaBounty says—but the fact is that these are not the same as wild fish. They are less mature than the fish normally eaten now. Why should we believe their claims...especially since the FDA won't show us any documentation to back them up?
Do the fish suffer from abnormally rapid growth? Do they suffer from their altered anatomy? We don't know. AquaBounty, of course, says they don't. The FDA doesn't believe we have the right to know.
There is one fact that we do know about these fish. They'll be factory-farmed. Fish raised in such conditions generally suffer horribly in extremely crowded conditions eating toxic food, which is then transferred to us when eaten. For years, farmed salmon have been known to be dangerously infested with dioxins, PCBs, and toxaphene, which are known as carcinogens, and several other dangerous chemicals.
Fish Sterile & Unable to Escape?
AquaBounty claims that the fish are sterile females and that they cannot escape from the fish farms. There are two clear problems with these claims. The first is the assumption that the techniques used to make the fish sterile will last. Genetic alterations have been known to reverse, so we don't know if these salmon would necessarily be unable to breed. The claim that they can't escape from the farms because they aren't located near the ocean is belied by the fact that AquaBounty does not intend to raise the fish themselves. Their plan is to sell eggs to fish farms. Are we to believe that they won't sell to a farmer because he's located by the ocean?
We do know that farmed fish are already escaping into the wild with devastating effects on the wild salmon. Should we believe the promises of AquaBounty that their fish cannot escape and, if they do, that they cannot breed?
Peter Melcher of the UK's Soil Association, says, "Once you have bombarded an animal with other genes, the DNA is unstable, and there is no guarantee these fish will remain sterile. It poses far too great a risk to wild salmon. A fish that grows so quickly is also likely to lose some of the nutritional benefits. There is no such thing as a free salmon lunch and we will pay the price."
What we do know about these fish is terrible. What we don't know could be even worse. But the FDA doesn't think we have the right to know, and AquaBounty is only telling us what they want us to hear.
Who Runs AquaBounty?
When trying to understand the nature of a corporation and its focus, it helps to look at who is on its board of directors. In AquaBounty's case, it's very revealing.
Richard J. Clothier is the Non-Executive Chairman of the Board and Chairman of the Nominations and Corporate Governance Committee. His career has put him at the head of agribusiness corporations, including Robinson plc, which makes packaging for supermarket products, and Spearhead International Ltd, which operates factory farms in several countries. Before that, he was a CEO with Dalgety plc, a now-defunct manufacturer of products sold by supermarkets. He retired recently as Group Chief Executive of PGI Group plc, an agribusiness firm involved in tea, flower, and produce production in Africa.
Other key figures with AquaBounty are former officers and executives of major multinational corporations, investment firms, medical device manufacturers, and pharmaceuticals. Stotish, the President and CEO, was previously an officer with a pharmaceutical firm involved in genetic manipulation. Elliot Entis, a board member, specializes in commercial and regulatory issues of biotech food introduction. Another board and audit committee member, Richard Huber, was a chairman and president of the giant health insurer, Aetna.
The collection of men at the helm of AquaBounty is remarkable for their connections with the worst sort of Agribusiness, Big Pharma, and multinational corporations. These are men who are practiced at the art of making money at any cost to the public and environment. It seems that they've found the perfect vehicle for their sort of expertise in AquaBounty.
The FDA's "Public Meeting"
The FDA will probably hold a "public meeting" of an advisory committee in early fall, supposedly for obtaining public input. It's a standard procedure before final approval of a drug. Limited information, consisting of material, picked by the FDA, that supports the product, is given to the public. It promises to be no more than a show. Gregory Jaffe, biotechnology project director of the Center for Science in the Public Interest, says that the public is not given adequate time to analyze the data provided.
Belying the true status of GM salmon in the FDA, a government official has stated anonymously, "It's going to be a P.R. issue." Let's hope so!
Here's what you can do:
Go to this page (http://tinyurl.com/39ubv2m) provided by the Organic Consumers Association. It will help you send a letter to President Obama and Margaret A. Hamburg, Commissioner of the FDA. A sample letter is provided, which you may alter if you wish. The Organic Consumers Association will deliver the message for you. It's quick and easy.
Let's stop Frankenfish!
The original can be read here: http://bit.ly/a9P27t
THE NEW STREAMLINED RSN LOGIN PROCESS: Register once, then login and you are ready to comment. All you need is a Username and a Password of your choosing and you are free to comment whenever you like! Welcome to the Reader Supported News community.
ARTICLE VIEWS: 3225
MOST RECENT ARTICLES
In what could hopefully lead to a significant change in the nature of Third World development financing, a new research paper from the International Monetary Fund (IMF) admits that the strong
Wednesday, 01 July 2015
Puerto Rico's public utility company, the Puerto Rico Electric Power Authority (PREPA), reached a deal Wednesday with investors to extend debt negotiations. PREPA will pay $416 million immediately
Wednesday, 01 July 2015
Obama proves what happens when a seemingly once-a-generation chance for reform is sabotaged. Sanders, with a cleaner, more progressive record, is grabbing the reform baton. The nomination aside, his
Wednesday, 01 July 2015
Although various Baloch separatist leaders of the Balochistan province are still opposing the China-Pakistan Economic Corridor (CPEC), yet case of Nawabzada Braham¬¬dagh Bugti, the leader of the
Wednesday, 01 July 2015
Responding to the article: How I Would Vote on The Greek Referendumhttp://readersupportednews.org/opinion2/277-75/31026-focus-how-i-would-vote-in-the-greek-referendum: By Joseph Stiglitz, Guardian
Tuesday, 30 June 2015
EU Acknowledges Pre-existing CHALLENGE to CETA; Thank you. ***President Jose Barroso (EU Commission), President Herman Van Rompuy (EU Council), President Schulz (EU
Sunday, 28 June 2015
On Sunday 5th July, Greeks will vote in a referendum. They will have to vote Yes or No, as it is the case for any referendum. The subject is the whole set of proposals made by “institutions”
Sunday, 28 June 2015